Background {#Sec1}
==========

Previously, abdominal surgery is the leading cause of adhesive small bowel obstruction (SBO) \[[@CR1], [@CR2]\]. Patients receiving colorectal surgeries are at higher risk of postoperative SBO, which might be resulting from the dissection in the peritoneal cavity \[[@CR3]--[@CR5]\]. It has been shown that the incidence of SBO requiring hospitalization following colorectal resection was 3.6% 3 years after surgery \[[@CR6]\] and that SBO was found in \~ 9% patients with colorectal procedures \[[@CR7]\]. However, the said findings were obtained based on information from various colorectal surgeries, such as anorectal procedures, or different diseases like carcinomatosis. Therefore, these findings cannot demonstrate the accurate incidence of benign SBO following curative resection in rectal cancer patients.

To date, there have been limited studies about the risk factors of benign SBO following colorectal cancer surgery \[[@CR6], [@CR8]--[@CR12]\]. In the present study, we determined the incidence of benign SBO and its risk factors following curative resection for rectal cancer, providing guidance for operative treatment of rectal cancer patients.

Methods {#Sec2}
=======

Patients and the diagnosis of benign SBO {#Sec3}
----------------------------------------

This retrospective research was approved by the Ethics Committee of Tianjin Medical University Cancer Institute and Hospital. Written informed consent for publication of the patient's information was obtained from all patients.

In total, 3472 consecutive patients undergoing rectal cancer surgery at the Department of Colorectal Cancer, Tianjin Medical University Cancer Institute and Hospital, between January 2003 and December 2012 were enrolled. The clinicopathological data were extracted from patient files. The patients' information was collected, such as age, gender, type of primary surgery, surgery duration, and hospitalized days. The patients were followed up with an average time of 68 (7--89) months.

The diagnosis criteria of benign SBO were as follows: patients showing clinical symptoms as below, including ventosity, constipation, colicky abdominal pain, nausea, and hyperactive bowel sounds. The patients with SBO were further confirmed when fluid levels in dilated loops were shown by the plain abdominal X-ray. The contents of serum carcinoembryonic antigen in patients were also measured. Besides, the possible tumor recurrence or carcinomatosis in patients was determined by the imaging procedures of computed tomography (CT) and positron emission tomography (PET).

The exclusion criteria were as follows: patients with distant metastasis (e.g., liver, lung, brain, or peritoneal carcinomatosis), patients died 30 days after surgery, patients with SBO resulting from cancer recurrence or peritoneal carcinomatosis, and patients without complete follow-up data.

Statistical analysis {#Sec4}
--------------------

The SPSS 13.0 software (SPSS, Chicago, IL, USA) was used for statistical analysis. The correlation of benign SBO and clinicopathological factors was evaluated by a chi-square (*χ*^*2*^) test or Fisher's exact test. Risk factors for benign SBO following curative resection in rectal cancer patients were analyzed by univariate and multivariate logistic regression analysis. *P* \<  0.05 was taken as statistically significant.

Results {#Sec5}
=======

Two hundred and fifty-three patients (7.3%, 253/3472) hospitalized were diagnosed with benign SBO. Among these patients, 247 cases (97.6%, 247/253) were first subjected to conservative treatment. The conservative treatment included venous transfusion, total parenteral nutrition, gastric tube insertion, coloclysis, and bowel rest. However, conservative treatment was ineffective for 95 patients, who were then subjected to surgeries. Additionally, six (2.4%) patients underwent laparotomy in the initial 12 h of hospitalization due to the possibility of small bowel strangulation indicated by imaging.

The categories of surgery included lysis of adhesions, small bowel resection, ileocecectomy, and colectomy. When comparing to the conservative treatment group, surgical treatment group possessed a lower incidence of recurrent benign SBO, higher mortality, and longer hospital stay (Table [1](#Tab1){ref-type="table"}). It was noteworthy that most patients undergoing operation received primary conservative treatment; therefore, a careful determination of hospitalized days should be taken.Table 1The outcome of patients with small bowel obstruction (SBO) through different treatments (*N* = 253)Conservative treatment group\
(*n* = 152)Surgical treatment group\
(*n* = 101)*P* valueSBO recurrence54 (35.5%)15 (14.8%)\< 0.001Mean hospital stay (days)5.814.5\< 0.001Mortality2 (1.32%)4 (3.96%)0.176

As shown in Table [2](#Tab2){ref-type="table"}, multiple variables were likely correlated with benign SBO, including surgical approach, radiotherapy, antiadhesive materials, pelvic peritoneum sutured, blood loss, and tumor stage (TNM). Then the multivariate logistic regression analysis demonstrated that open surgery (OR, 8.25; 95% CI, 2.18--17.32; *P* \<  0.001) and radiotherapy (OR, 6.13; 95% CI, 1.47--15.36; *P* \<  0.001) were the independent risk factors of benign SBO in rectal cancer patients receiving curative resection (Table [3](#Tab3){ref-type="table"}).Table 2Risk factors for benign small bowel obstruction (SBO) by the univariate analysisVariablesNo. of patientsNo. of SBOOR95% CI*P* valueAge0.820.62--1.070.14 ≤ 60131885 \> 602154168Gender0.870.67--1.120.267 Male1805123 Female1667130Type of surgeryNANA0.299 Anterior resection2547176 Abdominoperineal resection78367 Hartmann's operation14210Surgical approach1.591.21--2.090.001 Open2014172 Laparoscopic145881Duration of surgery0.780.59--1.010.062 ≤ 3 h2378160 \> 3 h109493Radiotherapy2.491.92--3.23\< 0.001 Yes901113 No2571140Chemotherapy0.810.63--1.070.144 Yes2341160 No113193Antiadhesive materials1.421.05--1.930.023 Yes2489197 No98356Pelvic peritoneum sutured1.481.12--1.960.007 Yes2638174 No83479Blood loss0.710.54--0.930.012 ≤ 4002513166 \> 40095987Previous laparotomy0.750.35--1.620.598 Yes1257 No3347246Tumor stage (TNM)NANA0.043 I51235 II129578 III1665140Table 3Independent risk factors for benign small bowel obstruction (SBO) by logistic regression analysisVariablesχ^2^*P* valueOR95% CIOpen surgery15.07\< 0.0018.252.18--17.32Radiotherapy11.69\< 0.0016.131.47--15.36

Discussion {#Sec6}
==========

SBO is a potentially life-threatening complication after primary rectal cancer surgery. Though the patients undergoing colorectal surgery are at high risk of SBO \[[@CR3], [@CR5]\], there have been limited studies about the accurate incidence of SBO following colorectal operation \[[@CR4], [@CR6], [@CR7], [@CR13]--[@CR16]\]. It has been reported that the occurrence rate of SBO following colorectal resection varied between 1.5--12.5% \[[@CR7], [@CR15]\] and 24--32.6% \[[@CR6], [@CR14], [@CR16]\]. In this study, the incidence of benign SBO following rectal cancer resection was 7.3% (253/3472), which was lower compared with previous studies \[[@CR6], [@CR7], [@CR14]--[@CR16]\]. This difference might be resulted from the technological innovation, especially after the wide application of laparoscopic surgery \[[@CR6]\]. The incidence of adhesive SBO was shown to be 32.6% in a 10-year follow-up study \[[@CR16]\]. However, the average follow-up period in our study was 68 months, possibly leading to the lower benign SBO incidence. It has been found that the average period between primary colorectal operation and SBO was 8.4 years \[[@CR17]\]. Therefore, a long-range follow-up is required for determining the accurate incidence of SBO in rectal cancer patients receiving initial operation.

In our study, the results showed that open surgery was a risk factor for benign SBO following rectal cancer operation, concurring with a previous finding, increased incidence of SBO after laparotomy \[[@CR18]\]. Studies have shown that the abdominal wall damage and intestinal operation increased inflammatory reactions \[[@CR19]\], possibly resulting in the occurrence of SBO after an open rectectomy \[[@CR8]\]. In contrast, multiple studies have demonstrated that laparoscopic proctectomy could reduce adhesion-related complications and produce better short-term outcome \[[@CR20]--[@CR22]\]. Besides, in this study, the incidence of benign SBO following rectal cancer surgery in the laparoscopic group was much lower compared with the open surgical group. Taken together, the results demonstrated the advantages of laparoscopy, providing a theoretical basis for treating rectal cancer patients using laparoscopic surgery.

Owing to the advantages of adjuvant radiotherapy, an increasing number of rectal cancer patients choose this option. But the long-range effects of radiotherapy should be completely studied to avoid the undesired side effects. It is well established that bowel obstruction is a long-term post-irradiation complication, and the incidence of bowel obstruction is increased when large quantities of small bowel are exposed to irradiation, especially the doses more than 50--55 Gy \[[@CR23]\]. In the long term, small bowel, affected by heavy quantities of irradiation could develop fibrosis and ischemia, might show as SBO. However, the incidence of post-irradiation SBO varies a lot, and no definite reasons could account for this variation. The fixed loops of small bowel in pelvis were observed in 65% of patients receiving postoperative irradiation relative to 18% of patients without operation \[[@CR24]\]. As fixed bowel maintains location during the treatment, the fixed bowel is potentially exposed to a significantly higher amount of irradiation compared with mobile bowel. Therefore, caution should be taken in the application of radiotherapy. A previous study showed that no difference in the occurrence rate of SBO was observed between surgery group (11%) and surgery combined with short-term preoperative irradiation group (11%) during a 5.1-year follow-up, suggesting the superiority of short-term preoperative irradiation over postoperative irradiation \[[@CR25]\]. However, in our study, most patients (683/901) undergoing radiotherapy were treated with postoperative irradiation. And we found that radiotherapy was the risk factor for SBO in rectal cancer patients subjected to radical resection, which was in line with previous findings \[[@CR9]\]. Taken together, these results reinforced the superiority of preoperative radiotherapy to reduce the long-run risk of developing SBO.

Notably, a recent study examined the risk factors for SBO that occurred within 30 days following anterior resection for rectal cancer \[[@CR10]\]. Patients with perioperative complications other than SBO and with simultaneous resection of other organs were excluded from the study. The univariate logistic regression was conducted to screen for the factors related to the occurrence of SBO; the identified factors were then used in a multivariate logistic model to evaluate the independent risk factors for SBO; they found D3 node dissection and defunctioning ileostomy formation were the independent risk factors for early postoperative SBO after anterior resection for rectal cancer. Therefore, basically, their research and our research are methodologically consistent; the biggest difference lies in the subjects of interest. The subjects with a long-term follow-up (68 months) in our study might result in the finding of different risk factors for SBO from previous studies.

Conclusion {#Sec7}
==========

In conclusion, we found that open surgery and radiotherapy were the independent risk factors of benign SBO following curative resection in rectal cancer patients. Therefore, laparoscopic surgery was confirmed to be a useful countermeasure against the long-term risk of benign SBO.
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